IL143278A0 - Genetic supressor elements against human immunodeficiency virus - Google Patents
Genetic supressor elements against human immunodeficiency virusInfo
- Publication number
- IL143278A0 IL143278A0 IL14327899A IL14327899A IL143278A0 IL 143278 A0 IL143278 A0 IL 143278A0 IL 14327899 A IL14327899 A IL 14327899A IL 14327899 A IL14327899 A IL 14327899A IL 143278 A0 IL143278 A0 IL 143278A0
- Authority
- IL
- Israel
- Prior art keywords
- supressor
- genetic
- immunodeficiency virus
- human immunodeficiency
- against human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21875598A | 1998-12-22 | 1998-12-22 | |
PCT/US1999/030187 WO2000037635A2 (en) | 1998-12-22 | 1999-12-17 | Genetic suppressor elements against human immunodeficiency virus |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143278A0 true IL143278A0 (en) | 2002-04-21 |
Family
ID=22816389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14327899A IL143278A0 (en) | 1998-12-22 | 1999-12-17 | Genetic supressor elements against human immunodeficiency virus |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1144621A2 (en) |
JP (1) | JP2002536964A (en) |
AU (1) | AU770885B2 (en) |
CA (1) | CA2355836A1 (en) |
IL (1) | IL143278A0 (en) |
WO (1) | WO2000037635A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6316210B1 (en) * | 1995-12-20 | 2001-11-13 | Subsidiary No. 3, Inc. | Genetic suppressor elements against human immunodeficiency virus |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94482A (en) * | 1989-05-25 | 2003-09-17 | Univ Duke | Transdominant repressor mutant of retroviral protein, dna encoding the protein and process for their preparation and use thereof |
US5217889A (en) * | 1990-10-19 | 1993-06-08 | Roninson Igor B | Methods and applications for efficient genetic suppressor elements |
WO1993012230A1 (en) * | 1991-12-13 | 1993-06-24 | Sri International | Triple-helix formation at (punpyn).(punpyn) tracts |
US6107062A (en) * | 1992-07-30 | 2000-08-22 | Inpax, Inc. | Antisense viruses and antisense-ribozyme viruses |
EP0865282A4 (en) * | 1995-08-25 | 2002-01-16 | Univ California | Chimeric antiviral agents which incorporate rev binding nucleic acides |
US5753490A (en) * | 1995-11-28 | 1998-05-19 | Clinical Technologies, Inc. | Recombinant HIV and modified packaging cells and method for treating acquired immune deficiency syndrome |
US6426412B1 (en) * | 1995-12-20 | 2002-07-30 | Subsidiary No. 3, Inc. | Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements |
US6071743A (en) * | 1997-06-02 | 2000-06-06 | Subsidiary No. 3, Inc. | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
-
1999
- 1999-12-17 EP EP99966409A patent/EP1144621A2/en not_active Withdrawn
- 1999-12-17 IL IL14327899A patent/IL143278A0/en unknown
- 1999-12-17 WO PCT/US1999/030187 patent/WO2000037635A2/en not_active Application Discontinuation
- 1999-12-17 AU AU21954/00A patent/AU770885B2/en not_active Ceased
- 1999-12-17 JP JP2000589689A patent/JP2002536964A/en active Pending
- 1999-12-17 CA CA002355836A patent/CA2355836A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000037635A3 (en) | 2001-10-18 |
WO2000037635A2 (en) | 2000-06-29 |
AU2195400A (en) | 2000-07-12 |
CA2355836A1 (en) | 2000-06-29 |
EP1144621A2 (en) | 2001-10-17 |
AU770885B2 (en) | 2004-03-04 |
JP2002536964A (en) | 2002-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2337755B (en) | Virus vaccine | |
GB2353370B (en) | Cooking system | |
EP1041888A4 (en) | Anti-retroviral immunogens, preparation and use | |
GB9812613D0 (en) | Vaccine | |
GB9904991D0 (en) | Genetic screening | |
GB9826069D0 (en) | HIV vaccine | |
EP1169452A4 (en) | Viral variants | |
GB0027072D0 (en) | Vaccine | |
GB9809666D0 (en) | Modified viruses | |
ZA98475B (en) | Transgenic virus | |
IL143278A0 (en) | Genetic supressor elements against human immunodeficiency virus | |
GB9925432D0 (en) | Virus preparation | |
GB9702990D0 (en) | Virus vaccine | |
DE69940886D1 (en) | Hiv impfstoff | |
GB9811171D0 (en) | Viral vector | |
GB9911599D0 (en) | Comb | |
AU7105500A (en) | Genetic suppressor elements against human immunodeficiency virus | |
GB9912277D0 (en) | Replaceable tine point combination | |
GB9925434D0 (en) | Virus Preparation | |
GB9825951D0 (en) | Viral therapeutics | |
GB9825955D0 (en) | Viral therapeutics | |
GB9930881D0 (en) | Modified viral glycoproteins | |
GB2327065B (en) | Folding trap | |
GB9920824D0 (en) | Virus assay | |
CA80050S (en) | Shovel |